|
Day 2
|
|
Thursday, April 26, 2012
|
|
6:30 am -
7:30 am
|
|
|
7:00 am -
8:00 am
|
|
|
8:00 am -
8:15 am
|
|
|
8:15 am -
9:30 am
|
|
|
9:30 am -
10:15 am
|
Women’s Initiatives in the Healthy People 2020 Program |
- Hear an overview of the initiative and its relationship to women’s services across the nation
- What are the main objectives and goals and what are the opportunities for your service line?
- How can the interventions and resources available assist you in improving your patient population health?
|
|
Michelle Berlin, MD, MPH
Director
OHSU National Center of Excellence in Women’s Health
|
|
|
|
|
10:15 am -
10:45 am
|
|
|
10:45 am -
12:00 pm
|
|
|
12:00 pm -
1:00 pm
|
Redesigning a Women’s Service Line to Address New Categories in Women’s Health |
- Describe the expanded definition of women’s health and its impact on designing a service line
- List the broader categories of care that a redesigned women’s service line can encompass
- Formulate the collaborations that differentiate your service line
|
|
Mary Reich Cooper, MD, JD
Co-Chair
Women's Health Council of Rhode Island;
Senior Vice President and Chief Quality Officer
Lifespan Corporation
Assistant Professor of Medicine (Research)
The Warren Alpert Medical School at Brown University
|
|
Karen Rosene-Montella, MD
Chief of Medicine, SVP Women’s Services
Lifespan Corp;
Co-Chair,
Women's Health Council of Rhode Island
|
|
|
|
|
1:00 pm -
2:00 pm
|
|
|
2:00 pm -
2:45 pm
|
Concurrent Tracks |
Track I: Revenue and Reimbursements -
Women’s and Children’s Health Business Development |
- How can specialty women’s centers radically improve your economic
and social bottom line?
- What physician alignment strategies are the most successful in
women’s services? (New planning and compensation models)
- Why are Children’s Hospitals getting into the business of Women’s
Health?
|
|
Vicki Lucas, PhD
President
Vicki Lucas, LLC, Women's Health Business Consultants
Co-Editor
AWHONN's Book on Women's Health
|
|
|
|
|
|
Track II: Women’s Health Resources and Information -
Update from the Center for Disease Control and
Prevention |
- Hear new guidelines for women
- What are the latest recommendations?
- Discuss science and resources available from the CDC for women’s
health professionals
|
|
Yvonne Green
Director, Office of Women’s Health
Center for Disease Control and Prevention (CDC)
|
|
|
|
|
|
|
|
|
2:45 pm -
3:30 pm
|
|
|
3:30 pm -
4:00 pm
|
|
|
4:00 pm -
5:00 pm
|
Turn up the Heat - Women can take it! |
- Ways to successfully build a women’s product line using existing services
- Discuss methodology to become a center of excellence- with or without 4 walls
- Learn strategies to build a culture of survivability in today’s heated health care market
|
|
Becky Hardie, RN,C-OB, MS HCAD
Vice President, Women's & Children's Services
Baylor All Saints Medical Center’s Andrews Women’s Hospital
|
|
Janice Whitmire, MBA-HCM
Administrator
Baylor All Saints Medical Center’s Andrews Women’s Hospital
|
| Moderator: TBD |
| Other Panelists TBD |
|
|
|
5:00 pm -
5:45 pm
|
Closing Keynote Address: The Impact of Sex and Gender on Healthcare Innovation |
- Provide a brief history of women’s health to the present day
- Explain the impact of sex/gender on health
- Recommend strategies that sex/gender can impact innovation and education to improve health of women and men
|
|
Saralyn Mark, MD
Stellar Medicine: A Journey Through the Universe of Women’s Health;
Affiliate Professor and Distinguished Research Fellow,
George Mason University School of Public Policy;
Associate Professor adjunct of Medicine and Ob/GYN,
Yale and Georgetown Schools of Medicine;
Medical Contributor, ABC News, Good Morning America Health
|
|
|
|
|
5:45 pm -
6:00 pm
|
|
|
6:00 pm -
7:00 pm
|
|
|
7:00 pm -
8:30 pm
|
Private Screening of Filmmaker Liz Canner’s - ORGASM INC. |
| In the shocking and hilarious documentary ORGASM INC., filmmaker Liz Canner takes a job editing erotic videos for a drug trial for a pharmaceutical company. Her
employer is developing what they hope will be the first Viagra drug for women that wins FDA approval to treat a new disease: Female Sexual Dysfunction (FSD) |
|
|
|
